B261, LSL
This serves as a Development and Launch Center for oral dosage forms, which supports the fastest possible development and commercialization of Small Molecules Medicines.
The buildings are constructed according to the latest energy and sustainability standards in accordance with Roche specifications. The production rooms are designed using cleanroom technology and qualified according to GMP/GEP.
Images
Is your company missing here?
List your involvement for free — with your logo and a link to your company profile.